Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study
Crossref DOI link: https://doi.org/10.1007/s40123-017-0114-6
Published Online: 2017-11-10
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ch’ng, Soon W.
Brent, Alexander J.
Empeslidis, Theodoros
Konidaris, Vasileios
Banerjee, Somnath